A detailed history of Concourse Financial Group Securities, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 6,899 shares of LLY stock, worth $6.27 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
6,899
Previous 6,302 9.47%
Holding current value
$6.27 Million
Previous $4.9 Million 27.42%
% of portfolio
0.4%
Previous 0.32%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $432,747 - $542,696
597 Added 9.47%
6,899 $6.25 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $331,039 - $442,884
559 Added 9.73%
6,302 $4.9 Million
Q4 2023

Feb 07, 2024

BUY
$525.19 - $619.13 $528,341 - $622,844
1,006 Added 21.24%
5,743 $3.35 Million
Q3 2023

Oct 25, 2023

BUY
$434.7 - $599.3 $147,363 - $203,162
339 Added 7.71%
4,737 $2.54 Million
Q2 2023

Aug 10, 2023

BUY
$350.74 - $468.98 $163,444 - $218,544
466 Added 11.85%
4,398 $2.06 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $87,597 - $102,879
-282 Reduced 6.69%
3,932 $1.35 Million
Q4 2022

Jan 30, 2023

SELL
$321.55 - $374.67 $85,853 - $100,036
-267 Reduced 5.96%
4,214 $0
Q3 2022

Nov 15, 2022

SELL
$296.48 - $337.87 $36,467 - $41,558
-123 Reduced 2.67%
4,481 $1.45 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $80,274 - $94,253
288 Added 6.67%
4,604 $1.49 Million
Q1 2022

May 09, 2022

SELL
$234.69 - $291.66 $792,782 - $985,227
-3,378 Reduced 43.9%
4,316 $1.24 Million
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $38,224 - $47,436
170 Added 2.26%
7,694 $2.13 Million
Q3 2021

Nov 09, 2021

SELL
$221.6 - $272.71 $60,275 - $74,177
-272 Reduced 3.49%
7,524 $1.74 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $194,091 - $251,055
-1,075 Reduced 12.12%
7,796 $1.79 Million
Q1 2021

May 13, 2021

BUY
$164.32 - $212.72 $20,211 - $26,164
123 Added 1.41%
8,871 $1.66 Million
Q4 2020

Feb 02, 2021

BUY
$130.46 - $172.63 $159,422 - $210,953
1,222 Added 16.24%
8,748 $1.48 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $77,935 - $90,146
533 Added 7.62%
7,526 $1.11 Million
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $165,477 - $199,150
1,213 Added 20.99%
6,993 $1.15 Million
Q1 2020

May 13, 2020

SELL
$119.05 - $147.35 $12,500 - $15,471
-105 Reduced 1.78%
5,780 $802,000
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $433,774 - $537,268
4,057 Added 221.94%
5,885 $774,000
Q3 2019

Nov 13, 2019

SELL
$106.79 - $116.16 $490,806 - $533,871
-4,596 Reduced 71.54%
1,828 $204,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $1,661 - $1,939
-15 Reduced 0.23%
6,424 $711,000
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $73,019 - $85,949
-656 Reduced 9.25%
6,439 $834,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $435,884 - $488,322
4,116 Added 138.17%
7,095 $821,000
Q3 2018

Nov 13, 2018

BUY
$85.86 - $107.31 $255,776 - $319,676
2,979 New
2,979 $320,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.